The FDA approved new treatments for HIV, RSV, and allergic fungal rhinosinusitis, alongside a wound care gel recall, marking a busy week in infectious disease regulation. At the same time, major ...
Discussions at the American Academy of Dermatology annual meeting highlighted a rapidly evolving treatment landscape for ...
Hosted on MSN
Dupixent updates, access hurdles and new hope
Dupixent continues to transform treatment for atopic dermatitis and other conditions, with new FDA approvals and updated clinical guidelines boosting its role. But patients and providers still face ...
FDA drug alerts in infectious diseases, including new drug approvals, safety warnings, recalls, and changes in indications.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results